Literature DB >> 9088660

Royal jelly consumption and hypersensitivity in the community.

R Leung1, A Ho, J Chan, D Choy, C K Lai.   

Abstract

BACKGROUND: Royal jelly consumption has recently been linked with acute asthma, anaphylaxis and death. A cross-sectional survey was conducted to determine the prevalence of and the relationship between royal jelly consumption and hypersensitivity reactions.
METHODS: 1472 hospital employees of a teaching hospital in Hong Kong completed a questionnaire on royal jelly consumption and related allergic symptoms, and 176 questionnaire respondents and 300 consecutive asthma clinic patients were skin tested to royal jelly.
RESULTS: Royal jelly consumption was high, with 461 out of 1472 subjects (31.3%) having taken royal jelly in the past. A total of nine subjects reported 14 adverse reactions to royal jelly, including urticaria, eczema, rhinitis and acute asthma. Thirteen out of 176 questionnaire respondents (7.4%) and 23 out of 300 consecutive asthma clinic attendees (7.3%) had positive skin test to pure royal jelly. All but one of the 36 subjects with positive royal jelly skin test were atopic to other common allergens. Positive associations were found between positive royal jelly skin test and atopy (OR = 33.73, 95% CI 4.51 to 252.11), adverse reactions to royal jelly and a history of clinical allergy (OR = 2.88, 95% CI 0.72 to 11.58), but not between royal jelly symptoms and previous royal jelly intake.
CONCLUSION: Royal jelly consumption is high in the community of Hong Kong. Atopic individuals are at high risk of sensitization to royal jelly but the precise relationship between royal jelly use, positive royal jelly skin test and clinical manifestations of adverse reactions to royal jelly, remains to be defined.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9088660

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  8 in total

1.  Traditional remedies and food supplements. A 5-year toxicological study (1991-1995).

Authors:  D Shaw; C Leon; S Kolev; V Murray
Journal:  Drug Saf       Date:  1997-11       Impact factor: 5.606

2.  Efficacy of royal jelly on methotrexate-induced systemic oxidative stress and damage to small intestine in rats.

Authors:  Leylagül Kaynar; Aysun Cetin; Sibel K Hacioglu; Barış Eser; İsmail Koçyigit; Özlem Canöz; Arzu Tasdemir; Canan Karadag; Fatih Kurnaz; Recep Saraymen; Sibel Silici
Journal:  Afr J Tradit Complement Altern Med       Date:  2012-04-02

3.  Oral allergy syndrome in a child provoked by royal jelly.

Authors:  Fantini Paola; Delle Donne Pantalea; Calogiuri Gianfranco; Ferrannini Antonio; Vacca Angelo; Nettis Eustachio; Di Leo Elisabetta
Journal:  Case Rep Med       Date:  2014-03-31

4.  Food allergy-lessons from Asia.

Authors:  Bee Wah Lee; Lynette Pei-Chi Shek; Irvin Francis A Gerez; Shu E Soh; Hugo P Van Bever
Journal:  World Allergy Organ J       Date:  2008-07       Impact factor: 4.084

5.  Topical royal jelly alleviates symptoms of pruritus in a murine model of allergic contact dermatitis.

Authors:  Katsunori Yamaura; Ayana Tomono; Eriko Suwa; Koichi Ueno
Journal:  Pharmacogn Mag       Date:  2013-01       Impact factor: 1.085

6.  Potential health risks of complementary alternative medicines in cancer patients.

Authors:  U Werneke; J Earl; C Seydel; O Horn; P Crichton; D Fannon
Journal:  Br J Cancer       Date:  2004-01-26       Impact factor: 7.640

7.  Evaluation of propolis, honey, and royal jelly in amelioration of peripheral blood leukocytes and lung inflammation in mouse conalbumin-induced asthma model.

Authors:  Waleed K El-Aidy; Ahmad A Ebeid; Abd El-Raouf M Sallam; Ibrahim E Muhammad; Ayman T Abbas; M A Kamal; Sayed Sartaj Sohrab
Journal:  Saudi J Biol Sci       Date:  2014-11-22       Impact factor: 4.219

Review 8.  Honey Bee Products: Preclinical and Clinical Studies of Their Anti-inflammatory and Immunomodulatory Properties.

Authors:  Hesham R El-Seedi; Nehal Eid; Aida A Abd El-Wahed; Mostafa E Rateb; Hanan S Afifi; Ahmed F Algethami; Chao Zhao; Yahya Al Naggar; Sultan M Alsharif; Haroon Elrasheid Tahir; Baojun Xu; Kai Wang; Shaden A M Khalifa
Journal:  Front Nutr       Date:  2022-01-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.